Cargando…

Humoral Hypercalcemia in a Patient with Cholangiocellular Carcinoma – Effective Therapy with Denosumab

Patient: Male, 65 Final Diagnosis: Humoral hypercalcemia Symptoms: Syncope Medication: — Clinical Procedure: Establishing diagnosis • lowering hypercalcemia with denosumab Specialty: Endocrinology and Metabolic OBJECTIVE: Educational purpose (only if useful for a systematic review or synthesis) BACK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harsch, Igor Alexander, Konturek, Peter Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753663/ https://www.ncbi.nlm.nih.gov/pubmed/31492829 http://dx.doi.org/10.12659/AJCR.917275

Ejemplares similares

Hypercalcemia related to cholangiocellular carcinoma
por: Onalan, Erhan
Publicado: (2019)

Update on Locoregional Therapies for Cholangiocellular Carcinoma
por: Morawitz, Janna, et al.
Publicado: (2023)

Mitochondriome and Cholangiocellular Carcinoma
por: Bahitham, Wesam, et al.
Publicado: (2014)

Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report
por: Roukain, Abdallah, et al.
Publicado: (2022)

Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa
por: Giri, Dinesh, et al.
Publicado: (2015)

Adhesion Ileus after Fecal Microbiota Transplantation in Long-Standing Radiation Colitis
por: Harsch, Igor Alexander, et al.
Publicado: (2019)

The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into “Old” Diseases
por: Harsch, Igor Alexander, et al.
Publicado: (2018)

Hypercalcemia following discontinuation of denosumab therapy: A systematic review
por: Horiuchi, Keisuke, et al.
Publicado: (2021)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma
por: Makino, Hirofumi, et al.
Publicado: (2022)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

Denosumab for management of severe hypercalcemia in primary hyperparathyroidism
por: Eremkina, Anna, et al.
Publicado: (2020)

Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy
por: Jumpertz von Schwartzenberg, Reiner, et al.
Publicado: (2015)

A Cholangiocellular Carcinoma of the Fowl (Gallus Domesticus)
por: Wight, P. A. L.
Publicado: (1961)

Denosumab-Induced Rebound Hypercalcemia Treated With Bisphosphonates in a Pediatric Patient
por: Gandolfi, Anne, et al.
Publicado: (2023)

Prevalence of antibodies against COVID-19 in the staff of a COVID-19 regular ward
por: Harsch, Igor Alexander, et al.
Publicado: (2020)

Gut–Liver Axis: How Do Gut Bacteria Influence the Liver?
por: Konturek, Peter Christopher, et al.
Publicado: (2018)

Prognostic Impact of Tumor Budding in Intrahepatic Cholangiocellular Carcinoma
por: Budau, Klara-Luisa, et al.
Publicado: (2022)

Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
por: Abd Jalil, Afdhal Afiq, et al.
Publicado: (2021)

Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma
por: Ashihara, Norihiro, et al.
Publicado: (2016)

Symptomatic Rebound Hypercalcemia After Denosumab Discontinuation in a Pediatric Patient With Cherubism
por: Marpuri, Ian, et al.
Publicado: (2021)

SUN-513 Parathyromatosis: A Case of Stubborn Hypercalcemia Treated with Denosumab
por: Ventura, Kenilia, et al.
Publicado: (2019)

Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment
por: Hu, Mimi I., et al.
Publicado: (2013)

Spontaneous Hepatocellular and Cholangiocellular Carcinoma in the Duck. An Experimental Study
por: Campbell, J. G.
Publicado: (1949)

NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
por: Maeda, Shin, et al.
Publicado: (2021)

Humoral hypercalcemia of pregnancy treated with bisphosphonates
por: Koren, Ronit, et al.
Publicado: (2018)

Effect of liver transplantation in combined hepatocellular and cholangiocellular carcinoma: a case series
por: Wu, Di, et al.
Publicado: (2015)

Identification of Novel Biomarker Candidates for the Immunohistochemical Diagnosis of Cholangiocellular Carcinoma
por: Padden, Juliet, et al.
Publicado: (2014)

The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022)

Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI
por: Trejo, Pamela, et al.
Publicado: (2018)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases
por: Patil, Madhuri D, et al.
Publicado: (2023)

Cholangiocellular carcinoma occurrence after HCV eradication therapy: case series and review of the literature
por: Cerban, Razvan, et al.
Publicado: (2022)

Leptin, Obestatin and Apelin levels in patients with obstructive sleep apnoea syndrome
por: Zirlik, Sabine, et al.
Publicado: (2011)

Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review
por: Camponovo, C., et al.
Publicado: (2020)

Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on (18)F-FDG PET/CT
por: Erdoğan, Ezgi Başak, et al.
Publicado: (2018)

SAT-120 Humoral Hypercalcemia of Malignancy Caused by Squamous Cell Carcinoma of the Penis
por: Kanta, Romana, et al.
Publicado: (2020)

SAT258 Successful Treatment Of Adult T-cell Leukemia-lymphoma Induced Hypercalcemia With Denosumab
por: Yuksel, Simge, et al.
Publicado: (2023)

Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Small cholangiolocellular carcinoma that was difficult to distinguish from cholangiocellular carcinoma: a case report
por: Ishii, Norihiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_db7dnbgap5hei08o202uih7pt4